HL Deb 18 March 2002 vol 632 cc122-3WA
Lord Morris of Manchester

asked Her Majesty's Government:

How many infections have been recorded from the prescription for haemophilia patients of recombinant clotting factors; how many recorded infections there have been to date from prescribing plasma products; and whether they will detail the infections caused by each treatment. [HL2860]

Lord Hunt of Kings Heath

Information on all adverse events associated with medicinal products is not collected centrally. However, reports of suspected adverse drug reactions are made voluntarily by doctors to the Medicines Control Agency through the Yellow Card Scheme. The Medicines Control Agency has received notification of one case of Hepatitis A and one of septicaemia in patients receiving recombinant factor VIII, and two cases of Hepatitis B infection in two patients receiving human albumin solution. A report of a suspected reaction does not necessarily mean that it has been caused by the drug.

Forward to